Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells.

X Y Guo; J M Cuillerot; T Wang; Y Wu; R Arlinghaus; D Claxton; C Bachier; J Greenberger; I Colombowala; A B Deisseroth

doi:10.1038/sj.onc.1201999

Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells.

Identifier:nobleid.org/w1/20260515/49BA05DB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/49BA05DB.svg?ark=w1%2F20260515%2F49BA05DB)](https://nobleid.org/work/w1/20260515/49BA05DB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells.

Identifier:nobleid.org/w1/20260515/49BA05DB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/49BA05DB.svg?ark=w1%2F20260515%2F49BA05DB)](https://nobleid.org/work/w1/20260515/49BA05DB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work